A Case for Chloroquine or Hydroxychloroquine in COVID-19
A lot has been said about the potential of hydroxychloroquine or chloroquine, as a standalone monotherapy or combined with azithromycin and, perhaps, zinc supplement, in the treatment of COVID-19 patients. While claims of treatment effectiveness have been touted by physicians in China, and South Korea, in the West a lot of skepticism about this treatment continues to linger in the minds of many health professionals who are hesitant or even reluctant to use either drug in treating SARS-CoV-2 patients with only mild symptoms, due to the lack of reliable data and the apparent availability of only sketchy evidence of its effectiveness, because of the limitations of studies carried out so far, in this respect. Given the anecdotal nature of claims of treatment effectiveness by some physicians here and there in the USA, the limited sample size and the lack of a control group in a study conducted by a renown French professor of infectious diseases, Didier Raoult, rather than stoking clari...